Raffles Medical Group Ltd
SGX:BSL

Watchlist Manager
Raffles Medical Group Ltd Logo
Raffles Medical Group Ltd
SGX:BSL
Watchlist
Price: 1.01 SGD Market Closed
Market Cap: 1.9B SGD

Intrinsic Value

The intrinsic value of one BSL stock under the Base Case scenario is 1.05 SGD. Compared to the current market price of 1.01 SGD, Raffles Medical Group Ltd is Undervalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BSL Intrinsic Value
1.05 SGD
Undervaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Raffles Medical Group Ltd

What is Valuation History?
Compare BSL to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BSL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Raffles Medical Group Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Raffles Medical Group Ltd

Current Assets 500.3m
Cash & Short-Term Investments 334.2m
Receivables 154.9m
Other Current Assets 11.3m
Non-Current Assets 989.7m
Long-Term Investments 246.1m
PP&E 722.3m
Intangibles 15.3m
Other Non-Current Assets 6m
Efficiency

Free Cash Flow Analysis
Raffles Medical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Raffles Medical Group Ltd

Revenue
764.3m SGD
Cost of Revenue
-98.5m SGD
Gross Profit
665.8m SGD
Operating Expenses
-582.9m SGD
Operating Income
82.8m SGD
Other Expenses
-19.1m SGD
Net Income
63.7m SGD
Fundamental Scores

BSL Profitability Score
Profitability Due Diligence

Raffles Medical Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Gross Margin is Increasing
51/100
Profitability
Score

Raffles Medical Group Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

BSL Solvency Score
Solvency Due Diligence

Raffles Medical Group Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
High Altman Z-Score
78/100
Solvency
Score

Raffles Medical Group Ltd's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BSL Price Targets Summary
Raffles Medical Group Ltd

Wall Street analysts forecast BSL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSL is 1.19 SGD with a low forecast of 1.03 SGD and a high forecast of 1.39 SGD.

Lowest
Price Target
1.03 SGD
2% Upside
Average
Price Target
1.19 SGD
18% Upside
Highest
Price Target
1.39 SGD
37% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BSL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BSL stock?

The intrinsic value of one BSL stock under the Base Case scenario is 1.05 SGD.

Is BSL stock undervalued or overvalued?

Compared to the current market price of 1.01 SGD, Raffles Medical Group Ltd is Undervalued by 3%.

Back to Top